Overview
Dennis Willerford is an Oncologist and a Hematologist Oncology provider in Poulsbo, Washington. Dr. Willerford is rated as an Advanced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Waldenstrom Macroglobulinemia, Adult Immune Thrombocytopenia, Small Cell Lung Cancer (SCLC), and Lung Adenocarcinoma. Dr. Willerford is currently accepting new patients.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- PPO
- HMO
- MANAGED MEDICAID PLAN
- HMO
- INDEMNITY
- POS
- PPO
- PPO
Locations
Virginia Mason Medical Center
John Flores is a Hematologist Oncology specialist and a Hematologist in Seattle, Washington. Dr. Flores has been practicing medicine for over 16 years and is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Prostate Cancer, Muscle Invasive Bladder Cancer, WT1-Related Wilms Tumor Syndromes, Prostatectomy, and Splenectomy. Dr. Flores is currently accepting new patients.
The Association Of University Physicians
Scott Tykodi is an Oncologist in Seattle, Washington. Dr. Tykodi is rated as an Elite provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, Adult Soft Tissue Sarcoma, and Nephrectomy. Dr. Tykodi is currently accepting new patients.
Song Zhao is an Oncologist in Anchorage, Washington. Dr. Zhao is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, and Prostate Cancer. Dr. Zhao is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Adult Immune ThrombocytopeniaDr. Willerford isDistinguished. Learn about Adult Immune Thrombocytopenia.
- Chronic Lymphocytic Leukemia (CLL)Dr. Willerford isDistinguished. Learn about Chronic Lymphocytic Leukemia (CLL).
- Hemangioma Thrombocytopenia SyndromeDr. Willerford isDistinguished. Learn about Hemangioma Thrombocytopenia Syndrome.
- Lung AdenocarcinomaDr. Willerford isDistinguished. Learn about Lung Adenocarcinoma.
- Paget Disease of the BreastDr. Willerford isDistinguished. Learn about Paget Disease of the Breast.
- Richter SyndromeDr. Willerford isDistinguished. Learn about Richter Syndrome.
- Advanced
- Acute Mountain SicknessDr. Willerford isAdvanced. Learn about Acute Mountain Sickness.
- ALK-Positive Non-Small Cell Lung CancerDr. Willerford isAdvanced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- AnemiaDr. Willerford isAdvanced. Learn about Anemia.
- AngiosarcomaDr. Willerford isAdvanced. Learn about Angiosarcoma.
- B-Cell LymphomaDr. Willerford isAdvanced. Learn about B-Cell Lymphoma.
- Breast CancerDr. Willerford isAdvanced. Learn about Breast Cancer.
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Dr. Willerford isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Myeloblastic Leukemia with MaturationDr. Willerford isExperienced. Learn about Acute Myeloblastic Leukemia with Maturation.
- Acute Myeloblastic Leukemia without MaturationDr. Willerford isExperienced. Learn about Acute Myeloblastic Leukemia without Maturation.
- Acute Myeloid Leukemia (AML)Dr. Willerford isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Adult Soft Tissue SarcomaDr. Willerford isExperienced. Learn about Adult Soft Tissue Sarcoma.
- AgranulocytosisDr. Willerford isExperienced. Learn about Agranulocytosis.